A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Stryker Steps up to the Plate at Chickasaw Bricktown Ballpark with Its SmartRobotics™ Technology

Today, Stryker makes a stop with its “SmartRobotics™ Stadium” booth at Chickasaw Bricktown Ballpark in Oklahoma City as part of its 10-city tour in partnership with Minor League Baseball™ (MiLB™).

On July 22 and July 23, Dodgers fans are encouraged to come out to a ballgame and see the latest innovation in joint replacement technology, Mako SmartRobotics™, on full display in the stadium. Stryker will also have fun, interactive activities between innings, as well as local orthopaedic surgeons on-site to speak about joint health and treatment options, including Mako SmartRobotics™ robotic-arm assisted surgery.

“As we emerge from the pandemic, it will be encouraging to see fans back in the stands cheering on the Dodgers as they take on the Sugar Land Skeeters,” said Don Payerle, president of Stryker’s Joint Replacement division. “We hope they take the opportunity to stop by our SmartRobotics™ Stadium and learn about the ways Stryker can help with knee and hip pain that may have been left untreated during the pandemic.”

Fans can learn more about Stryker throughout the games with videoboard commercials and promotions, including a seat upgrade for a lucky fan. In addition to the game day events, local Mako-certified orthopaedic surgeons will be back at the ballpark on Monday, August 9, for an educational seminar about joint health, the latest technologies available and surgical and nonsurgical options available to patients.

Elective Surgeries Are Back in the Lineup

The pandemic forced many individuals and their physicians to delay necessary orthopaedic procedures, which can result in increased use of medications, a more difficult recovery and more complicated surgeries, according to a recent Lancet study.1 Now that many communities are fully open again, it is important for those living with joint pain to revisit their treatment plans and for healthcare professionals to educate them on their options to help prevent further pain and complications.

Individuals are encouraged to come out to the Chickasaw Bricktown Ballpark and learn about new advancements designed to keep those with joint pain active, including Mako SmartRobotics™ technology. Fans can visit the SmartRobotics™ Stadium booth near the Mickey Mantle Gate. To register for the seminar and learn more about joint health treatment options, please visit here.

Lastly, as part of its “Own the Walk” charitable program, Stryker will donate $1 to K9s For Warriors – the nation’s largest provider of service dogs to American veterans living with military-related trauma – for every walk issued to a batter during the regular season. Stryker has been a committed partner of K9s For Warriors since 2015, having sponsored 31 service dogs to date — the largest number by any corporate partner.

All surgery carries risk. See your orthopaedic surgeon to discuss your potential benefits and risks. Not all patients will have the same postoperative recovery and activity level. Individual results vary.

Originally reported here.

 

SourceStryker
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy